Company profile: GlycosBio
1.1 - Company Overview
Company description
- Provider of sustainable chemicals from renewable feedstocks and lipid systems, including Activated Oil Systems for therapeutic delivery, microbiota and bioavailability/nutrition research, clinical validation (in vitro and in vivo), IP licensing, and the GB-AD22 atopic dermatitis clinical study.
Products and services
- Activated Oil Systems: Custom-engineered library of lipids that enhances transdermal and systemic delivery and performance of therapeutic agents through the skin and within the body across targeted therapeutic applications
- Microbiota Research: Develops research-grade approaches to shift microbiota to target bacterial and viral pathogens while protecting commensal bacteria, preserving beneficial communities
- Bioavailability / Nutrition Research: Architects patient-specific nutritional lipid systems that improve nutrient bioavailability and balance the microbiota for specific patient populations in targeted nutritional applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GlycosBio
Douglas Laboratories
HQ: United States
Website
- Description: Provider of nutritional supplements researched, developed, and manufactured to support healthy lifestyles across health functions, including detox, bone & joint, heart & metabolic, cognitive & mood, digestive, and N-Acetyl-L-Cysteine; also provides customized practice support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Douglas Laboratories company profile →
BBI Healthcare
HQ: United Kingdom
Website
- Description: Provider of an innovative portfolio of healthcare products, engaged in development, manufacturing, and distribution, located in Crumlin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBI Healthcare company profile →
OptiBiotix
HQ: United Kingdom
Website
- Description: Provider of microbiome-modulating strains, compounds, and formulations used as food ingredients and supplements to prevent and manage disease. Products include SlimBiome for hunger-free weight management, LPLDL (Lactobacillus plantarum) to lower cholesterol and blood pressure, CholBiome supplements using LPLDL, and OptiBiome, OptiScreen, and OptiBiotic platforms for screening and developing microbiome modulators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OptiBiotix company profile →
Protein
HQ: Spain
Website
- Description: Provider of protein-based products focused on collagen-building, operating as a manufacturing company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein company profile →
Func Food
HQ: Finland
Website
- Description: Provider of sports nutrition products, developed and manufactured by Func Food Finland Oy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Func Food company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GlycosBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GlycosBio
2.2 - Growth funds investing in similar companies to GlycosBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GlycosBio
4.2 - Public trading comparable groups for GlycosBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →